| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S1388-1981(02)00331-1 |
| P698 | PubMed publication ID | 12531544 |
| P50 | author | Yusuf A. Hannun | Q87620042 |
| P2093 | author name string | Charles E Chalfant | |
| Benjamin J Pettus | |||
| P2860 | cites work | Analysis of functional domains of angiotensin II type 2 receptor involved in apoptosis | Q22010261 |
| Molecular cloning and characterization of a human mitochondrial ceramidase | Q22253989 | ||
| Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase | Q22254143 | ||
| Cloning and characterization of a novel human alkaline ceramidase. A mammalian enzyme that hydrolyzes phytoceramide | Q24291239 | ||
| Ceramide kinase, a novel lipid kinase. Molecular cloning and functional characterization | Q24294548 | ||
| Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling? | Q24319856 | ||
| FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase | Q24323995 | ||
| Molecular cloning and characterization of a full-length complementary DNA encoding human acid ceramidase. Identification Of the first molecular lesion causing Farber disease | Q24336488 | ||
| The use of diglyceride kinase for quantifying ceramide | Q77875075 | ||
| Stress signals for apoptosis: ceramide and c-Jun kinase | Q77900365 | ||
| Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A | Q77985300 | ||
| Role of sphingosine 1-phosphate in the mitogenesis induced by oxidized low density lipoprotein in smooth muscle cells via activation of sphingomyelinase, ceramidase, and sphingosine kinase | Q78037718 | ||
| A possible role of nuclear ceramide and sphingosine in hepatocyte apoptosis in rat liver | Q78053115 | ||
| Inhibition of PKB/Akt1 by C2-ceramide involves activation of ceramide-activated protein phosphatase in PC12 cells. | Q54062670 | ||
| Distinct functions of SR proteins in alternative pre-mRNA splicing. | Q55066190 | ||
| Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells. | Q55475374 | ||
| CD95 Signaling via Ceramide-rich Membrane Rafts | Q57371964 | ||
| Ceramide glycosylation potentiates cellular multidrug resistance | Q57373871 | ||
| Selective hydrolysis of a mitochondrial pool of sphingomyelin induces apoptosis | Q57373873 | ||
| Activation energies for gas-phase dissociations of multiply charged ions from electrospray ionization mass spectrometry | Q58069614 | ||
| Direct Effect of Ceramide on the Mitochondrial Electron Transport Chain Leads to Generation of Reactive Oxygen Species | Q58116814 | ||
| BAD Enables Ceramide to Signal Apoptosis via Ras and Raf-1 | Q59123101 | ||
| Identification of Heterogeneous Ribonucleoprotein A1 as a Novel Substrate for Protein Kinase C ζ | Q59123103 | ||
| c-Jun is a downstream target for ceramide-activated protein phosphatase in A431 cells. | Q64967336 | ||
| Programmed cell death induced by ceramide | Q70619078 | ||
| Differential regulation of sphingomyelinase and ceramidase activities by growth factors and cytokines. Implications for cellular proliferation and differentiation | Q71743133 | ||
| Mechanism of phosphorylation of protein kinase B/Akt by a constitutively active 3-phosphoinositide-dependent protein kinase-1 | Q73006592 | ||
| Ceramide profiling of complex lipid mixtures by electrospray ionization mass spectrometry | Q73051257 | ||
| De novo-synthesized ceramide signals apoptosis in astrocytes via extracellular signal-regulated kinase | Q73127880 | ||
| Quantitative determination of ceramide using diglyceride kinase | Q73170808 | ||
| Implication of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis | Q73596247 | ||
| Direct inhibition of mitochondrial respiratory chain complex III by cell-permeable ceramide | Q73717907 | ||
| CD95/Fas-induced ceramide formation proceeds with slow kinetics and is not blocked by caspase-3/CPP32 inhibition | Q73717944 | ||
| Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bcl-2 | Q73919781 | ||
| Induction of p53-independent p21 during ceramide-induced G1 arrest in human hepatocarcinoma cells | Q73940009 | ||
| Activation of ERK1/2 and cPLA(2) by the p55 TNF receptor occurs independently of FAN | Q74062072 | ||
| Identification of intracellular ceramide target proteins by affinity chromatography and TID-ceramide photoaffinity labelling | Q74079499 | ||
| Interleukin-1beta induces chronic activation and de novo synthesis of neutral ceramidase in renal mesangial cells | Q74215676 | ||
| Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-alpha-induced cell death | Q74473415 | ||
| Nitric oxide donors induce stress signaling via ceramide formation in rat renal mesangial cells | Q74583650 | ||
| Participation of cathepsins B and D in apoptosis of PC12 cells following serum deprivation | Q77472042 | ||
| Tumor necrosis factor induces ceramide oscillations and negatively controls sphingolipid synthases by caspases in apoptotic Kym-1 cells | Q77545172 | ||
| Cathepsin D targeted by acid sphingomyelinase-derived ceramide | Q24529823 | ||
| Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest | Q24563429 | ||
| p53-dependent ceramide response to genotoxic stress | Q24564604 | ||
| PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid | Q24568285 | ||
| Modulation of Akt kinase activity by binding to Hsp90 | Q24648565 | ||
| Overexpression of acid ceramidase protects from tumor necrosis factor-induced cell death | Q24676003 | ||
| C26-CoA-dependent ceramide synthesis of Saccharomyces cerevisiae is operated by Lag1p and Lac1p | Q27932220 | ||
| Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis | Q28139061 | ||
| Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I | Q28204289 | ||
| SR proteins: a conserved family of pre-mRNA splicing factors | Q28240185 | ||
| Regulation of cell death protease caspase-9 by phosphorylation | Q28288607 | ||
| Reversible phosphorylation of Bcl2 following interleukin 3 or bryostatin 1 is mediated by direct interaction with protein phosphatase 2A | Q28291327 | ||
| Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals | Q28295232 | ||
| Purification and characterization of a novel ceramidase from Pseudomonas aeruginosa | Q28492756 | ||
| Identification and characterization of a sphingolipid delta 4-desaturase family | Q28506937 | ||
| Molecular cloning of the full-length cDNA encoding mouse neutral ceramidase. A novel but highly conserved gene family of neutral/alkaline ceramidases | Q28513560 | ||
| Tumor necrosis factor- induces adhesion molecule expression through the sphingosine kinase pathway | Q29041393 | ||
| SR proteins and splicing control | Q29619936 | ||
| Activation of a nuclear sphingomyelinase in radiation-induced apoptosis | Q31812327 | ||
| Occurrence of ceramides and neutral glycolipids with unusual long-chain base composition in purified rat liver mitochondria | Q31864172 | ||
| Signalling sphingomyelinases: which, where, how and why? | Q33601457 | ||
| Glucosylceramide synthase does not attenuate the ceramide pool accumulating during apoptosis induced by CD95 or anti-cancer regimens | Q33914230 | ||
| Osmotic shock inhibits insulin signaling by maintaining Akt/protein kinase B in an inactive dephosphorylated state | Q33958497 | ||
| Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity | Q33980970 | ||
| Involvement of sphingomyelinases in TNF signaling pathways | Q34042929 | ||
| Current methods for the identification and quantitation of ceramides: an overview | Q34057367 | ||
| Protein kinase B (PKB/Akt)--a key regulator of glucose transport? | Q34189344 | ||
| Enzymes of sphingolipid metabolism: from modular to integrative signaling | Q34220989 | ||
| Expression of neutral sphingomyelinase identifies a distinct pool of sphingomyelin involved in apoptosis. | Q34420769 | ||
| Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis. | Q34438239 | ||
| Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway | Q34889125 | ||
| Regulation of cell cycle progression and nuclear affinity of the retinoblastoma protein by protein phosphatases. | Q36050995 | ||
| Intracellular translocation of fluorescent sphingolipids in cultured fibroblasts: endogenously synthesized sphingomyelin and glucocerebroside analogues pass through the Golgi apparatus en route to the plasma membrane | Q36211654 | ||
| Role of the modular domains of SR proteins in subnuclear localization and alternative splicing specificity | Q36268125 | ||
| Association of phosphorylated serine/arginine (SR) splicing factors with the U1-small ribonucleoprotein (snRNP) autoantigen complex accompanies apoptotic cell death | Q36400294 | ||
| Fas-induced apoptosis of T cells occurs independently of ceramide generation | Q36654745 | ||
| Ceramide-binding and activation defines protein kinase c-Raf as a ceramide-activated protein kinase | Q37477854 | ||
| Bcl-2 interrupts the ceramide-mediated pathway of cell death. | Q37583838 | ||
| Sphingolipid metabolism in cultured fibroblasts: microscopic and biochemical studies employing a fluorescent ceramide analogue | Q37610409 | ||
| Characterization of a ceramide-activated protein kinase: stimulation by tumor necrosis factor alpha | Q37617716 | ||
| Pre-mRNA splicing in plants: characterization of Ser/Arg splicing factors | Q37685703 | ||
| An update of the enzymology and regulation of sphingomyelin metabolism | Q37923512 | ||
| Ataxia telangiectasia-mutated gene product inhibits DNA damage-induced apoptosis via ceramide synthase | Q38323889 | ||
| Ceramide inhibits cell proliferation through Akt/PKB inactivation and decreases melanin synthesis in Mel-Ab cells | Q38525013 | ||
| TNFalpha-induced glutathione depletion lies downstream of cPLA(2) in L929 cells | Q40771853 | ||
| Localization of neutral ceramidase in caveolin-enriched light membranes of murine endothelial cells | Q40776199 | ||
| A role for protein phosphatase 2A-like activity, but not atypical protein kinase Czeta, in the inhibition of protein kinase B/Akt and glycogen synthesis by palmitate | Q40778321 | ||
| Ordering of ceramide formation, caspase activation, and mitochondrial changes during CD95- and DNA damage-induced apoptosis | Q40850451 | ||
| Measurement of ceramide synthase activity | Q40865787 | ||
| Functional dichotomy of protein kinase C (PKC) in tumor necrosis factor-alpha (TNF-alpha ) signal transduction in L929 cells. Translocation and inactivation of PKC by TNF-alpha. | Q40869425 | ||
| Ceramide as an activator lipid of cathepsin D. | Q40874792 | ||
| Differential effects of sphingomyelin hydrolysis and resynthesis on the activation of NF-kappa B in normal and SV40-transformed human fibroblasts | Q40881783 | ||
| Glycosylation of ceramide potentiates cellular resistance to tumor necrosis factor-alpha-induced apoptosis | Q40922175 | ||
| Mass spectrometric identification of increased C16 ceramide levels during apoptosis | Q40922788 | ||
| Involvement of de novo ceramide biosynthesis in lymphotoxin-induced oligodendrocyte death | Q40936702 | ||
| A functional role for mitochondrial protein kinase Calpha in Bcl2 phosphorylation and suppression of apoptosis | Q41008797 | ||
| Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C? | Q41035572 | ||
| Potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivity. | Q41035943 | ||
| Induction of ceramide-mediated apoptosis by the anticancer phospholipid analog, hexadecylphosphocholine | Q41036914 | ||
| Phospholipase A2 is necessary for tumor necrosis factor alpha-induced ceramide generation in L929 cells | Q41100173 | ||
| Inhibition of carnitine palmitoyltransferase I augments sphingolipid synthesis and palmitate-induced apoptosis | Q41128299 | ||
| Phosphorylation of Raf by ceramide-activated protein kinase | Q41270560 | ||
| Regulation of Raf-1 kinase by TNF via its second messenger ceramide and cross-talk with mitogenic signalling | Q42034188 | ||
| Bimodal regulation of ceramidase by interleukin-1beta. Implications for the regulation of cytochrome p450 2C11. | Q42441554 | ||
| Long chain ceramides activate protein phosphatase-1 and protein phosphatase-2A. Activation is stereospecific and regulated by phosphatidic acid | Q42474499 | ||
| Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate | Q42476162 | ||
| Mouse anti-ceramide antiserum: a specific tool for the detection of endogenous ceramide | Q42507051 | ||
| Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate | Q42556020 | ||
| Purification, characterization, molecular cloning, and subcellular distribution of neutral ceramidase of rat kidney | Q42648568 | ||
| Metabolism and apoptotic properties of elevated ceramide in HT29rev cells | Q42990368 | ||
| Kinase suppressor of Ras signals through Thr269 of c-Raf-1. | Q43514105 | ||
| Induction of apoptosis through B-cell receptor cross-linking occurs via de novo generated C16-ceramide and involves mitochondria | Q43559569 | ||
| p53 regulates ceramide formation by neutral sphingomyelinase through reactive oxygen species in human glioma cells | Q43583302 | ||
| Activation of a p53-independent, sphingolipid-mediated cytolytic pathway in p53-negative mouse fibroblast cells treated with N-methyl-N-nitro-N-nitrosoguanidine | Q43615470 | ||
| Rapid reactive oxygen species production by mitochondria in endothelial cells exposed to tumor necrosis factor-alpha is mediated by ceramide | Q43646549 | ||
| The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress. | Q43654457 | ||
| Effect of affinity for droplet surfaces on the fraction of analyte molecules charged during electrospray droplet fission | Q43769736 | ||
| De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1. | Q43860697 | ||
| Purification and characterization of ceramide-activated protein phosphatases | Q47710075 | ||
| Partial purification and characterization of sphingosine N-acyltransferase (ceramide synthase) from bovine liver mitochondrion-rich fraction | Q47877695 | ||
| Involvement of de novo ceramide biosynthesis in tumor necrosis factor-alpha/cycloheximide-induced cerebral endothelial cell death | Q47954345 | ||
| Purification and characterization of a membrane-bound nonlysosomal ceramidase from rat brain | Q48111911 | ||
| CD95(Fas/APO-1) signals ceramide generation independent of the effector stage of apoptosis. | Q51082157 | ||
| Ceramide induces hepatocyte cell death through disruption of mitochondrial function in the rat. | Q52524724 | ||
| Ceramide enables fas to cap and kill. | Q52542714 | ||
| Analysis of sphingomyelin, glucosylceramide, ceramide, sphingosine, and sphingosine 1-phosphate by tandem mass spectrometry. | Q52926527 | ||
| CD95 (Fas/APO-1) induces ceramide formation and apoptosis in the absence of a functional acid sphingomyelinase. | Q53435443 | ||
| P433 | issue | 2-3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ceramides | Q424213 |
| apoptotic process | Q14599311 | ||
| P304 | page(s) | 114-125 | |
| P577 | publication date | 2002-12-01 | |
| P1433 | published in | Biochimica et Biophysica Acta | Q864239 |
| P1476 | title | Ceramide in apoptosis: an overview and current perspectives | |
| P478 | volume | 1585 |
| Q39608488 | 5,7,3'-Trihydroxy-3,4'-dimethoxyflavone inhibits the tubulin polymerization and activates the sphingomyelin pathway |
| Q35912807 | A Conserved Circular Network of Coregulated Lipids Modulates Innate Immune Responses |
| Q43235892 | A PAMPA study of the permeability-enhancing effect of new ceramide analogues |
| Q33890589 | A hypothesis concerning a potential involvement of ceramide in apoptosis and acantholysis induced by pemphigus autoantibodies |
| Q40498233 | A mitochondrial pool of sphingomyelin is involved in TNFalpha-induced Bax translocation to mitochondria. |
| Q39566737 | A novel mechanism of dasatinib-induced apoptosis in chronic myeloid leukemia; ceramide synthase and ceramide clearance genes |
| Q44533963 | A sphingosine-dependent protein kinase that specifically phosphorylates 14-3-3 (SDK1) is identified as the kinase domain of PKCdelta: a preliminary note |
| Q36827084 | Ablation of dihydroceramide desaturase 1, a therapeutic target for the treatment of metabolic diseases, simultaneously stimulates anabolic and catabolic signaling |
| Q36362832 | Acid ceramidase (ASAH1) represses steroidogenic factor 1-dependent gene transcription in H295R human adrenocortical cells by binding to the receptor |
| Q47852896 | Acid ceramidase and its inhibitors: a de novo drug target and a new class of drugs for killing glioblastoma cancer stem cells with high efficiency |
| Q46460410 | Acid ceramidase confers radioresistance to glioblastoma cells |
| Q33648644 | Acid ceramidase is a novel drug target for pediatric brain tumors. |
| Q44846031 | Acid sphingomyelinase and inhibition by phosphate ion: role of inhibition by phosphatidyl-myo-inositol 3,4,5-triphosphate in oligodendrocyte cell signaling |
| Q92861486 | Activation of Mitochondrial Unfolded Protein Response in SHSY5Y Expressing APP Cells and APP/PS1 Mice |
| Q34486274 | Activation of neutral-sphingomyelinase, MAPKs, and p75 NTR-mediating caffeic acid phenethyl ester-induced apoptosis in C6 glioma cells |
| Q42814032 | Activation of serine/threonine protein phosphatase-1 is required for ceramide-induced survival of sympathetic neurons |
| Q35747758 | Activation of the unfolded protein response pathway causes ceramide accumulation in yeast and INS-1E insulinoma cells |
| Q33624807 | Adjustment of Dysregulated Ceramide Metabolism in a Murine Model of Sepsis-Induced Cardiac Dysfunction |
| Q37079752 | Akt2 and acid ceramidase cooperate to induce cell invasion and resistance to apoptosis |
| Q38089154 | Allylic structures in cancer drugs and body metabolites that control cell life and death |
| Q37168389 | Alteration of endoplasmic reticulum lipid rafts contributes to lipotoxicity in pancreatic β-cells |
| Q43270488 | Alteration of sphingolipid metabolism and pSTAT3 expression by dietary cholesterol in the gallbladder of hamsters |
| Q28297381 | Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged |
| Q46980724 | Amyloid beta peptide increases DP5 expression via activation of neutral sphingomyelinase and JNK in oligodendrocytes |
| Q46610352 | Amyloid-beta peptide enhances tumor necrosis factor-alpha-induced iNOS through neutral sphingomyelinase/ceramide pathway in oligodendrocytes |
| Q43700363 | An inositolphosphorylceramide synthase is involved in regulation of plant programmed cell death associated with defense in Arabidopsis |
| Q57374222 | An introduction to plant sphingolipids and a review of recent advances in understanding their metabolism and function |
| Q36327667 | Angiotensin II type 1 receptor blockers increase tolerance of cells to copper and cisplatin. |
| Q40082871 | Apoptosis induced by capsaicin in prostate PC-3 cells involves ceramide accumulation, neutral sphingomyelinase, and JNK activation |
| Q40290366 | Apoptosis induced by intracellular ceramide accumulation in MDA-MB-435 breast carcinoma cells is dependent on the generation of reactive oxygen species |
| Q40280745 | Apoptosis of human breast carcinoma cells in the presence of cis-platin and L-/D-PPMP: IV. Modulation of replication complexes and glycolipid: Glycosyltransferases |
| Q40565674 | Apoptosis of human carcinoma cells in the presence of inhibitors of glycosphingolipid biosynthesis: I. Treatment of Colo-205 and SKBR3 cells with isomers of PDMP and PPMP. |
| Q40509743 | Apoptosis of human carcinoma cells in the presence of potential anti-cancer drugs: III. Treatment of Colo-205 and SKBR3 cells with: cis -platin, Tamoxifen, Melphalan, Betulinic acid, L-PDMP, L-PPMP, and GD3 ganglioside |
| Q35552651 | Apoptosis, Chemoresistance, and Breast Cancer: Insights From the MCF-7 Cell Model System |
| Q37902996 | Apoptosis: why and how does it occur in biology? |
| Q34736760 | Apoptotic sphingolipid ceramide in cancer therapy |
| Q51980703 | Arabidopsis mutants lacking long chain base phosphate lyase are fumonisin-sensitive and accumulate trihydroxy-18:1 long chain base phosphate. |
| Q36911424 | Associations of Plasma Phospholipid SFAs with Total and Cause-Specific Mortality in Older Adults Differ According to SFA Chain Length |
| Q48532877 | Astrocytes and neuroinflammation in Alzheimer's disease. |
| Q40311939 | Asymmetric addition of ceramides but not dihydroceramides promotes transbilayer (flip-flop) lipid motion in membranes. |
| Q48649561 | Autocrine/paracrine sphingosine-1-phosphate fuels proliferative and stemness qualities of glioblastoma stem cells. |
| Q35225431 | Autophagy in the light of sphingolipid metabolism |
| Q52658167 | Bcr-Abl regulation of sphingomyelin synthase 1 reveals a novel oncogenic-driven mechanism of protein up-regulation. |
| Q41638170 | Benzoxazolone carboxamides: potent and systemically active inhibitors of intracellular acid ceramidase. |
| Q39813184 | Betuletol 3-methyl ether induces G(2)-M phase arrest and activates the sphingomyelin and MAPK pathways in human leukemia cells |
| Q34174979 | Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism |
| Q35852313 | Biologically active sphingolipids in cancer pathogenesis and treatment |
| Q46272016 | Bioluminescent assay for sphingolipid ceramide N-deacylase using Vibrio harveyi dark mutant M-17. |
| Q39990649 | C18 ceramide analysis in mammalian cells employing reversed-phase high-performance liquid chromatography tandem mass spectrometry. |
| Q33289080 | Cadmium-induced ceramide formation triggers calpain-dependent apoptosis in cultured kidney proximal tubule cells |
| Q92570264 | Cancer Metabolism and the Evasion of Apoptotic Cell Death |
| Q36002934 | Cardiomyocyte specific deficiency of serine palmitoyltransferase subunit 2 reduces ceramide but leads to cardiac dysfunction |
| Q58568746 | Ceramide Induces the Death of Retina Photoreceptors Through Activation of Parthanatos |
| Q39643015 | Ceramide Produces Apoptosis Through Induction of p27kip1by Protein Phosphatase 2A-dependent Akt Dephosphorylation in PC-3 Prostate Cancer Cells |
| Q46717211 | Ceramide activates a mitochondrial p38 mitogen-activated protein kinase: a potential mechanism for loss of mitochondrial transmembrane potential and apoptosis |
| Q34460818 | Ceramide and Related-Sphingolipid Levels Are Not Altered in Disease-Associated Brain Regions of APP and APP/PS1 Mouse Models of Alzheimer's Disease: Relationship with the Lack of Neurodegeneration? |
| Q43184244 | Ceramide and activated Bax act synergistically to permeabilize the mitochondrial outer membrane |
| Q37344754 | Ceramide and mitochondria in ischemia/reperfusion |
| Q46769758 | Ceramide catabolism critically controls survival of human dendritic cells |
| Q37797406 | Ceramide in Stress Response |
| Q28384389 | Ceramide induced mitophagy and tumor suppression |
| Q33226282 | Ceramide induces non-apoptotic cell death in human glioma cells |
| Q46834290 | Ceramide inhibits development and cytokinesis and induces apoptosis in preimplantation bovine embryos |
| Q40241323 | Ceramide is the key mediator of oxidative stress-induced apoptosis in retinal photoreceptor cells. |
| Q44754234 | Ceramide lances the lungs |
| Q33810952 | Ceramide promotes apoptosis in chronic myelogenous leukemia-derived K562 cells by a mechanism involving caspase-8 and JNK |
| Q40406772 | Ceramide regulation of the tumor suppressor phosphatase PTEN in rafts isolated from neurotumor cell lines |
| Q51803770 | Ceramide structural features required to stimulate ABCA1-mediated cholesterol efflux to apolipoprotein A-I. |
| Q41368828 | Ceramide synthase 4 regulates stem cell homeostasis and hair follicle cycling |
| Q41142815 | Ceramide synthase-4 orchestrates the cell proliferation and tumor growth of liver cancer in vitro and in vivo through the nuclear factor-κB signaling pathway |
| Q34963246 | Ceramide synthase-dependent ceramide generation and programmed cell death: involvement of salvage pathway in regulating postmitochondrial events |
| Q41995354 | Ceramide synthases 2, 5, and 6 confer distinct roles in radiation-induced apoptosis in HeLa cells |
| Q42597742 | Ceramide-1-phosphate, in contrast to ceramide, is not segregated into lateral lipid domains in phosphatidylcholine bilayers |
| Q44854751 | Ceramide-induced intracellular oxidant formation, iron signaling, and apoptosis in endothelial cells: protective role of endogenous nitric oxide |
| Q57373103 | Ceramide-platform formation and -induced biophysical changes in a fluid phospholipid membrane |
| Q36350326 | Ceramides And Stress Signalling Intersect With Autophagic Defects In Neurodegenerative Drosophila blue cheese (bchs) Mutants |
| Q57372654 | Ceramides and Sphingomyelins with High Proportions of Very Long-chain Polyunsaturated Fatty acids in Mammalian Germ Cells |
| Q39890580 | Ceramides: branched alkyl chains in the sphingolipid siblings of diacylglycerol improve biological potency. |
| Q46364465 | Changes in ceramide metabolism are essential in Madin-Darby canine kidney cell differentiation |
| Q34129700 | Characteristics of the rat cardiac sphingolipid pool in two mitochondrial subpopulations |
| Q46687728 | Characterization of overall ceramide species in human stratum corneum |
| Q27316398 | Chronic Voluntary Ethanol Consumption Induces Favorable Ceramide Profiles in Selectively Bred Alcohol-Preferring (P) Rats |
| Q39989458 | Chronic activation of neutral ceramidase protects beta-cells against cytokine-induced apoptosis |
| Q41978200 | Comprehensive quantification of ceramide species in human stratum corneum |
| Q91105624 | Concomitant deletion of HRAS and NRAS leads to pulmonary immaturity, respiratory failure and neonatal death in mice |
| Q24805055 | Cross-talk between phosphatidic acid and ceramide during ethanol-induced apoptosis in astrocytes |
| Q46644223 | Crystal structure of SmcL, a bacterial neutral sphingomyelinase C from Listeria. |
| Q34295244 | Cytoprotective effect of glucosylceramide synthase inhibition against daunorubicin-induced apoptosis in human leukemic cell lines |
| Q42123672 | Cytotoxic Activity and Structure Activity Relationship of Ceramide Analogues in Caki-2 and HL-60 Cells |
| Q41921715 | Cytotoxic activity and quantitative structure activity relationships of arylpropyl sulfonamides |
| Q38490440 | Cytotoxic effects of novel phytosphingosine derivatives, including N,N-dimethylphytosphingosine and N-monomethylphytosphingosine, in human leukemia cell line HL60. |
| Q36734546 | DNA damage induces down-regulation of UDP-glucose ceramide glucosyltransferase, increases ceramide levels and triggers apoptosis in p53-deficient cancer cells. |
| Q44799706 | De novo ceramide accumulation due to inhibition of its conversion to complex sphingolipids in apoptotic photosensitized cells. |
| Q53704434 | Death receptor 5-recruited raft components contributes to the sensitivity of Jurkat leukemia cell lines to TRAIL-induced cell death. |
| Q92823115 | Derailed Ceramide Metabolism in Atopic Dermatitis (AD): A Causal Starting Point for a Personalized (Basic) Therapy |
| Q39517521 | Determination of sphingosine kinase 2 activity using fluorescent sphingosine by capillary electrophoresis |
| Q34023846 | Dietary and behavioral interventions protect against age related activation of caspase cascades in the canine brain. |
| Q46669912 | Differential involvement of TNF alpha in hypoxic suppression of astrocyte glutamate transporters |
| Q44670472 | Differential sensitivity to short-chain ceramide analogues of human intestinal carcinoma cells grown in tumor spheroids versus monolayer culture |
| Q28301592 | Dihydroceramide hinders ceramide channel formation: Implications on apoptosis |
| Q53068633 | Dihydroceramide-desaturase-1-mediated caspase 9 activation through ceramide plays a pivotal role in palmitic acid-induced HepG2 cell apoptosis. |
| Q46346744 | Discovery of sphingosine 1-O-methyltransferase in rat kidney and liver homogenates |
| Q36169377 | Disruption of sphingolipid metabolism elicits apoptosis-associated reproductive defects in Drosophila. |
| Q40578192 | Distinct stress and cell destruction pathways are engaged by TNF and ceramide during apoptosis of MCF-7 cells |
| Q37458377 | Downregulation of neutral ceramidase by gemcitabine: Implications for cell cycle regulation |
| Q37138799 | Dynamic regulation of sphingosine-1-phosphate homeostasis during development of mouse metanephric kidney. |
| Q48146214 | Effect of Gegen Qinlian Decoction on Cardiac Gene Expression in Diabetic Mice. |
| Q46669301 | Effects of ceramide inhibition on experimental radiation-induced oral mucositis |
| Q36492334 | Effects of flavonoids on sphingolipid turnover in the toxin-damaged liver and liver cells |
| Q37253619 | Endocytosis and intracellular processing of BODIPY-sphingomyelin by murine CATH.a neurons |
| Q45096402 | Endostatin uncouples NO and Ca2+ response to bradykinin through enhanced O2*- production in the intact coronary endothelium |
| Q41846875 | Endothelial apoptosis induced by inhibition of integrins alphavbeta3 and alphavbeta5 involves ceramide metabolic pathways |
| Q42183157 | Endotoxin activates de novo sphingolipid biosynthesis via nuclear factor kappa B-mediated upregulation of Sptlc2. |
| Q37832047 | Enter the kill zone: initiation of death signaling during virus entry. |
| Q38668340 | Everybody needs sphingolipids, right! Mining for new drug targets in protozoan sphingolipid biosynthesis |
| Q24310311 | Expression cloning of a human cDNA restoring sphingomyelin synthesis and cell growth in sphingomyelin synthase-defective lymphoid cells |
| Q37271606 | Expression of ceramide glucosyltransferases, which are essential for glycosphingolipid synthesis, is only required in a small subset of C. elegans cells |
| Q36734697 | Expression of the follicular lymphoma variant translocation 1 gene in diffuse large B-cell lymphoma correlates with subtype and clinical outcome |
| Q36004699 | Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease |
| Q34489852 | Fibrillar amyloid-beta-activated human astroglia kill primary human neurons via neutral sphingomyelinase: implications for Alzheimer's disease |
| Q36179130 | Flavonoid compounds in maintenance of prostate health and prevention and treatment of cancer |
| Q33846993 | Fluorescent analogs of biomolecular building blocks: design, properties, and applications |
| Q36812440 | Folate stress induces apoptosis via p53-dependent de novo ceramide synthesis and up-regulation of ceramide synthase 6 |
| Q34614412 | Functional characterization of Aspergillus nidulans ypkA, a homologue of the mammalian kinase SGK |
| Q26823479 | Functional crosstalk between membrane lipids and TLR biology |
| Q34465333 | Further characterization of mammalian ceramide kinase: substrate delivery and (stereo)specificity, tissue distribution, and subcellular localization studies |
| Q40582092 | GSH depletion enhances adenoviral bax-induced apoptosis in lung cancer cells. |
| Q35839009 | Generation and metabolism of bioactive sphingosine-1-phosphate |
| Q34498625 | Glucose availability and glycolytic metabolism dictate glycosphingolipid levels |
| Q98613693 | Hepatic Expression of the Serine Palmitoyltransferase Subunit Sptlc2 Reduces Lipid Droplets in the Liver by Activating VLDL Secretion |
| Q40229102 | Highly sensitive determination of diverse ceramides in human hair using reversed-phase high-performance liquid chromatography-electrospray ionization mass spectrometry |
| Q40387380 | Human T-cell lymphotropic virus type I-transformed T-cells have a partial defect in ceramide synthesis in response to N-(4-hydroxyphenyl)retinamide |
| Q34599585 | Human meconium contains significant amounts of alkaline sphingomyelinase, neutral ceramidase, and sphingolipid metabolites |
| Q24633354 | Humanin is expressed in human vascular walls and has a cytoprotective effect against oxidized LDL-induced oxidative stress |
| Q24302262 | Identification of a family of animal sphingomyelin synthases |
| Q24653460 | Identification of aberrant forms of alkaline sphingomyelinase (NPP7) associated with human liver tumorigenesis |
| Q55342124 | Identification of radiation responsive genes and transcriptome profiling via complete RNA sequencing in a stable radioresistant U87 glioblastoma model. |
| Q37874939 | Implication of ceramide, ceramide 1-phosphate and sphingosine 1-phosphate in tumorigenesis |
| Q40300285 | Importance of C16 ceramide accumulation during apoptosis in prostate cancer cells |
| Q35968142 | Inactivation of ceramide transfer protein during pro-apoptotic stress by Golgi disassembly and caspase cleavage |
| Q33555622 | Increase in sphingolipid catabolic enzyme activity during aging |
| Q36814487 | Increased ceramide in brains with Alzheimer's and other neurodegenerative diseases |
| Q34674948 | Increased oxidative stress impairs adipose tissue function in sphingomyelin synthase 1 null mice |
| Q30443974 | Inducible nitric oxide has protective effect on fumonisin B1 hepatotoxicity in mice via modulation of sphingosine kinase |
| Q90010378 | Inflammatory Ocular Diseases and Sphingolipid Signaling |
| Q37404658 | Inorganic Nanocarriers Overcoming Multidrug Resistance for Cancer Theranostics. |
| Q40121297 | Insulin-like growth factor-1-dependent maintenance of neuronal metabolism through the phosphatidylinositol 3-kinase-Akt pathway is inhibited by C2-ceramide in CAD cells |
| Q36992077 | Integration of cytokine biology and lipid metabolism in stroke |
| Q37198666 | Interactions of PACAP and ceramides in the control of granule cell apoptosis during cerebellar development |
| Q34620309 | Interorganelle trafficking of ceramide is regulated by phosphorylation-dependent cooperativity between the PH and START domains of CERT. |
| Q35983863 | Involvement of ceramide in cell death responses in the pulmonary circulation |
| Q34130227 | Involvement of ceramide in ethanol-induced apoptotic neurodegeneration in the neonatal mouse brain |
| Q39259261 | Involvement of de novo ceramide synthesis in gamma-tocopherol and gamma-tocotrienol-induced apoptosis in human breast cancer cells |
| Q40240793 | Involvement of sphingolipids in apoptin-induced cell killing |
| Q39471980 | KLF6/Sp1 initiates transcription of the tmsg-1 gene in human prostate carcinoma cells: an exon involved mechanism |
| Q53247481 | Knock-out of β-glucosidase 2 has no influence on dextran sulfate sodium-induced colitis. |
| Q39132798 | Knockdown of core binding factorβ alters sphingolipid metabolism |
| Q34403752 | LASS5 is the predominant ceramide synthase isoform involved in de novo sphingolipid synthesis in lung epithelia |
| Q54450465 | Large-scale purification and characterization of recombinant Pseudomonas ceramidase: regulation by calcium. |
| Q40467658 | Light at the End of the "TUNEL"? Role of Ceramide in Seizure-induced Programmed Cell Death. |
| Q82136424 | Lipotoxicity in the heart |
| Q33435148 | Liquid chromatography-mass spectrometry for comprehensive profiling of ceramide molecules in human hair. |
| Q36580354 | Liver acid sphingomyelinase inhibits growth of metastatic colon cancer |
| Q43154877 | Locus-specific gene expression pattern suggests a unique propagation strategy for a giant algal virus |
| Q42426530 | Long-chain ceramide is a potent inhibitor of the mitochondrial permeability transition pore |
| Q33909832 | Loss of neutral ceramidase protects cells from nutrient- and energy -deprivation-induced cell death |
| Q24633453 | Mammalian ceramide synthases |
| Q34339067 | Mass spectrometry-based quantitative metabolomics revealed a distinct lipid profile in breast cancer patients. |
| Q54203079 | Mechanisms of Action and Cell Death Associated with Clostridium perfringens Toxins. |
| Q35060329 | Mechanisms of indomethacin-induced alterations in the choline phospholipid metabolism of breast cancer cells |
| Q34632669 | Mechanisms of mycotoxin-induced neurotoxicity through oxidative stress-associated pathways |
| Q34439404 | Mechanisms of sphingosine and sphingosine 1-phosphate generation in human platelets |
| Q27653166 | Mechanistic Insights into the Hydrolysis and Synthesis of Ceramide by Neutral Ceramidase |
| Q27932540 | Membrane topology and essential amino acid residues of Phs1, a 3-hydroxyacyl-CoA dehydratase involved in very long-chain fatty acid elongation |
| Q35850403 | Metabolic Conversion of Ceramides in HeLa Cells - A Cholesteryl Phosphocholine Delivery Approach |
| Q40390901 | Metabolic activity: a novel indicator of neuronal survival in the murine dopaminergic cell line CAD. |
| Q57364601 | Metabolism and physiological functions of sphingolipids |
| Q36259131 | Mitochondrial ceramide and the induction of apoptosis |
| Q34537129 | Mitochondrial dysfunction and increased reactive oxygen species impair insulin secretion in sphingomyelin synthase 1-null mice |
| Q40827049 | Modulation of host ROS metabolism is essential for viral infection of a bloom-forming coccolithophore in the ocean. |
| Q55663256 | Molecular Markers of Therapy-Resistant Glioblastoma and Potential Strategy to Combat Resistance. |
| Q89967597 | Molecular Mechanisms of Radiation-Induced Cancer Cell Death: A Primer |
| Q52593622 | Molecular Targeting of Acid Ceramidase in Glioblastoma: A Review of Its Role, Potential Treatment, and Challenges. |
| Q61758664 | Molecular biology in diagnostic histopathology. Part 3: signal transduction |
| Q37625399 | Molecular features of neural stem cells enable their enrichment using pharmacological inhibitors of survival-promoting kinases |
| Q46891967 | Molecular-dynamics simulation of a ceramide bilayer |
| Q36980340 | Multi-functional nanocarriers to overcome tumor drug resistance |
| Q35136562 | Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology |
| Q33923721 | Multiple roles for sphingolipids in steroid hormone biosynthesis |
| Q36790146 | Myocardial metabolism and cardiac performance in obesity and insulin resistance |
| Q38234908 | Nanodrug delivery in reversing multidrug resistance in cancer cells |
| Q50058499 | Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice |
| Q99554200 | Neutral ceramidase is a marker for cognitive performance in rats and monkeys |
| Q24634655 | Neutral sphingomyelinase 2 (nSMase2) is a phosphoprotein regulated by calcineurin (PP2B) |
| Q38726003 | New Aspects of Silibinin Stereoisomers and their 3-O-galloyl Derivatives on Cytotoxicity and Ceramide Metabolism in Hep G2 hepatocarcinoma Cell Line |
| Q34373087 | New role for EMD (emerin), a key inner nuclear membrane protein, as an enhancer of autophagosome formation in the C16-ceramide autophagy pathway |
| Q36526990 | Novel analogs of D-e-MAPP and B13. Part 1: synthesis and evaluation as potential anticancer agents |
| Q36498966 | Novel analogs of D-e-MAPP and B13. Part 2: signature effects on bioactive sphingolipids |
| Q57131204 | Novel glucosylceramide synthase inhibitor based prodrug copolymer micelles for delivery of anticancer agents |
| Q46461035 | Nuclear Ca2+ and the cAMP response element-binding protein family mediate a late phase of activity-dependent neuroprotection. |
| Q37925819 | Nuclear sphingolipid metabolism |
| Q58566319 | Overexpression of acid-Ceramidase (ASAH1) Protects Retinal Cells (ARPE19) from Oxidative Stress |
| Q36253615 | Oxidative stress kills human primary oligodendrocytes via neutral sphingomyelinase: implications for multiple sclerosis |
| Q37041154 | Peroxiredoxin 6 as an antioxidant enzyme: protection of lung alveolar epithelial type II cells from H2O2-induced oxidative stress |
| Q36628167 | Phosphatidylinositol transfer proteins and cellular nanoreactors for lipid signaling. |
| Q40432463 | Phosphorylation of Bad is not essential for PKB-mediated survival signaling in hemopoietic cells |
| Q36950921 | Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein |
| Q40062826 | Pivotal role of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in apoptosis and autophagy |
| Q92133797 | Pkh1p-Ypk1p and Pkh1p-Sch9p Pathways Are Activated by Acetic Acid to Induce a Mitochondrial-Dependent Regulated Cell Death |
| Q89530316 | Plasma Ceramides and Sphingomyelins in Relation to Atrial Fibrillation Risk: The Cardiovascular Health Study |
| Q46453140 | Potential role of sphingosine 1-phosphate in the pathogenesis of rheumatoid arthritis |
| Q42044971 | Presence of unsaturated sphingomyelins and changes in their composition during the life cycle of the moth Manduca sexta |
| Q48512547 | Protease-activated receptor-1 protects rat astrocytes from apoptotic cell death via JNK-mediated release of the chemokine GRO/CINC-1. |
| Q44397902 | Protection by D609 through cell-cycle regulation after stroke |
| Q41841689 | Protein kinase C-δ isoform mediates lysosome labilization in DNA damage-induced apoptosis |
| Q40074168 | Protein-sphingolipid interactions within cellular membranes |
| Q42928858 | Pseudomonas syringae infection triggers de novo synthesis of phytosphingosine from sphinganine in Arabidopsis thaliana |
| Q34320069 | Psyllium and fat in diets differentially affect the activities and expressions of colonic sphingomyelinases and caspase in mice |
| Q52814701 | Quantitative structural characterization of phosphatidylinositol phosphates from biological samples. |
| Q37494793 | RNAi-mediated functional analysis of pathways influencing cancer cell drug resistance. |
| Q37335620 | Rapid Detection of Necrosis in Breast Cancer with Desorption Electrospray Ionization Mass Spectrometry |
| Q39697531 | Reciprocal relationship between cytosolic NADH and ENOX2 inhibition triggers sphingolipid-induced apoptosis in HeLa cells |
| Q34559806 | Regulating survival and development in the retina: key roles for simple sphingolipids |
| Q36211046 | Regulation of cell migration by sphingomyelin synthases: sphingomyelin in lipid rafts decreases responsiveness to signaling by the CXCL12/CXCR4 pathway. |
| Q28384330 | Regulation of mitochondrial ceramide distribution by members of the BCL-2 family |
| Q34745605 | Regulation of phosphatidic Acid metabolism by sphingolipids in the central nervous system |
| Q36562936 | Remodeling of cellular cytoskeleton by the acid sphingomyelinase/ceramide pathway |
| Q37704672 | Renal Medulla is More Sensitive to Cisplatin than Cortex Revealed by Untargeted Mass Spectrometry-Based Metabolomics in Rats |
| Q35050155 | Resveratrol induced ER expansion and ER caspase-mediated apoptosis in human nasopharyngeal carcinoma cells |
| Q42742597 | Resveratrol triggers apoptosis through regulating ceramide metabolizing genes in human K562 chronic myeloid leukemia cells |
| Q42027274 | Role for furin in tumor necrosis factor alpha-induced activation of the matrix metalloproteinase/sphingolipid mitogenic pathway. |
| Q24801508 | Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review |
| Q40439690 | Role of ceramide in Ca2+-sensing receptor-induced apoptosis |
| Q36403166 | Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis |
| Q24657499 | Roles of bioactive sphingolipids in cancer biology and therapeutics |
| Q36293021 | SGK-1 protects kidney cells against apoptosis induced by ceramide and TNF-α |
| Q34390521 | Self-enhancement of hepatitis C virus replication by promotion of specific sphingolipid biosynthesis |
| Q39031586 | Silencing of LASS2/TMSG1 enhances invasion and metastasis capacity of prostate cancer cell |
| Q40571355 | Silica-induced apoptosis in mouse alveolar macrophages is initiated by lysosomal enzyme activity |
| Q43159538 | Simultaneous HPLC analysis of ceramide and dihydroceramide in human hairs |
| Q42468437 | Singlet oxygen-induced attenuation of growth factor signaling: possible role of ceramides |
| Q35778875 | Sphingolipid and ceramide homeostasis: potential therapeutic targets |
| Q36898608 | Sphingolipid metabolism and obesity-induced inflammation |
| Q50079745 | Sphingolipid pathway enzymes modulate cell fate and immune responses |
| Q26992148 | Sphingolipid signaling in metabolic disorders |
| Q37808219 | Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance |
| Q38045551 | Sphingolipids, lipotoxic cardiomyopathy, and cardiac failure |
| Q36533617 | Sphingomyelin organization is required for vesicle biogenesis at the Golgi complex. |
| Q39880179 | Sphingosine kinase isoforms regulate oxaliplatin sensitivity of human colon cancer cells through ceramide accumulation and Akt activation. |
| Q34810283 | Sphingosine kinase localization in the control of sphingolipid metabolism |
| Q38408286 | Sphingosine kinases/sphingosine-1-phosphate and death Signalling in APP-transfected cells |
| Q39320764 | Sphingosine metabolism as a therapeutic target in cutaneous melanoma. |
| Q85356970 | Sphingosine-1-phosphate and ceramide are associated with health and atresia of bovine ovarian antral follicles |
| Q37571963 | Sphingosine-dependent apoptosis: a unified concept based on multiple mechanisms operating in concert |
| Q44509765 | Sphingosine-dependent protein kinase-1, directed to 14-3-3, is identified as the kinase domain of protein kinase C delta |
| Q38339310 | Sphingosylphosphorylcholine and lysosulfatide have inverse regulatory functions in monocytic cell differentiation into macrophages |
| Q90614042 | Splicing factor SRSF1 controls T cell homeostasis and its decreased levels are linked to lymphopenia in systemic lupus erythematosus |
| Q91714604 | Stearoyl-CoA Desaturase 1 as a Therapeutic Target for the Treatment of Cancer |
| Q36559850 | Structure and function of glycosphingolipids and sphingolipids: recollections and future trends |
| Q36808041 | Superoxide dismutase protects against apoptosis and alveolar enlargement induced by ceramide |
| Q43119491 | Synthesis and characterization of long-chain tartaric acid diamides as novel ceramide-like compounds |
| Q34695541 | Synthesis and characterization of pseudocantharidins, novel phosphatase modulators that promote the inclusion of exon 7 into the SMN (survival of motoneuron) pre-mRNA |
| Q40189949 | Synthesis of 7-oxasphingosine and -ceramide analogues and their evaluation in a model for apoptosis |
| Q61454328 | TNFα mediated ceramide generation triggers cisplatin induced apoptosis in B16F10 melanoma in a PKCδ independent manner |
| Q35756892 | TRAIL and ceramide. |
| Q92711440 | Targeting alkaline ceramidase 3 alleviates the severity of nonalcoholic steatohepatitis by reducing oxidative stress |
| Q84578277 | Temporal expression profiles of ceramide and ceramide-related genes in wild-type and mPer1/mPer2 double knockout mice |
| Q35973562 | The Proto-oncogene PKCι regulates the alternative splicing of Bcl-x pre-mRNA. |
| Q37710735 | The ceramide transporter and the Goodpasture antigen binding protein: one protein--one function? |
| Q33466611 | The effect of hydrostatic pressure on model membrane domain composition and lateral compressibility. |
| Q44913883 | The histone deacetylase inhibitor LAQ824 induces human leukemia cell death through a process involving XIAP down-regulation, oxidative injury, and the acid sphingomyelinase-dependent generation of ceramide |
| Q37688434 | The interplay between bioactive sphingolipids and steroid hormones |
| Q49913969 | The investigation of ceranib-2 on apoptosis and drug interaction with carboplatin in human non small cell lung cancer cells in vitro. |
| Q40222818 | The murine TRAIL receptor signals caspase-independent cell death through ceramide |
| Q33737469 | The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies. |
| Q39949537 | The selective COX-2 inhibitor celecoxib modulates sphingolipid synthesis |
| Q46445861 | The sphingoid long chain base phytosphingosine activates AGC-type protein kinases in Saccharomyces cerevisiae including Ypk1, Ypk2, and Sch9. |
| Q38915115 | Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism |
| Q48197247 | Tolerogenic versus Immunogenic Lipidomic Profiles of CD11c+ Immune Cells and Control of Immunogenic Dendritic Cell Ceramide Dynamics |
| Q64937828 | Traceless synthesis of ceramides in living cells reveals saturation-dependent apoptotic effects. |
| Q40547157 | Transfection of 2,6 and 2,3-sialyltransferase genes and GlcNAc-transferase genes into human glioma cell line U-373 MG affects glycoconjugate expression and enhances cell death |
| Q49399657 | Translational Aspects of Sphingolipid Metabolism in Renal Disorders |
| Q36283299 | Tumor Necrosis Factor-α (TNFα)-induced Ceramide Generation via Ceramide Synthases Regulates Loss of Focal Adhesion Kinase (FAK) and Programmed Cell Death |
| Q90074713 | Unbalanced Sphingolipid Metabolism and Its Implications for the Pathogenesis of Psoriasis |
| Q36199812 | oxLDL and eLDL Induced Membrane Microdomains in Human Macrophages. |
Search more.